PACIFIC: a double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC

Schulz, C. and Laack, E. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. R. and de Wit, M. (2018) PACIFIC: a double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC. ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl4). p. 270. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 23 Jun 2020 14:04
Last Modified: 23 Jun 2020 14:04
URI: https://pred.uni-regensburg.de/id/eprint/15329

Actions (login required)

View Item View Item